5 April 2024
Pantherna and WACKER Expand mRNA Biopharmaceutical Collaboration
WACKER's Halle site will produce mRNA-based ARDS treatment using a scalable process. The facility, operational by mid-2024, marks a milestone in their collaboration with Pantherna.
